Extendicare Management

Management criteria checks 4/4

Extendicare's CEO is Michael Guerriere, appointed in Oct 2018, has a tenure of 5.5 years. total yearly compensation is CA$1.81M, comprised of 33.1% salary and 66.9% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth CA$1.89M. The average tenure of the management team and the board of directors is 2.5 years and 8.3 years respectively.

Key information

Michael Guerriere

Chief executive officer

CA$1.8m

Total compensation

CEO salary percentage	33.1%
CEO tenure	5.5yrs
CEO ownership	0.3%
Management average tenure	2.5yrs
Board average tenure	8.3yrs

Recent management updates

Recent updates

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

CEO Compensation Analysis

How has Michael Guerriere's remuneration changed compared to Extendicare's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	CA$2m	CA$600k	CA$34m
Sep 30 2023	n/a	n/a	CA$18m
Jun 30 2023	n/a	n/a	CA$1m
Mar 31 2023	n/a	n/a	CA$3m
Dec 31 2022	CA$2m	CA$600k	-CA$5m
Sep 30 2022	n/a	n/a	-CA$1m
Jun 30 2022	n/a	n/a	CA$6m
Mar 31 2022	n/a	n/a	CA$4m
Dec 31 2021	CA$2m	CA$600k	CA$8m
Sep 30 2021	n/a	n/a	CA$27m
Jun 30 2021	n/a	n/a	CA$59m
Mar 31 2021	n/a	n/a	CA$49m
Dec 31 2020	CA$2m	CA$600k	CA$42m
Sep 30 2020	n/a	n/a	CA$31m
Jun 30 2020	n/a	n/a	CA$2m
Mar 31 2020	n/a	n/a	CA$15m
Dec 31 2019	CA$2m	CA$600k	CA$15m
Sep 30 2019	n/a	n/a	CA$1m
Jun 30 2019	n/a	n/a	CA$4m
Mar 31 2019	n/a	n/a	CA$6m
Dec 31 2018	CA$829k	CA$118k	CA$8m

Compensation vs Market: Michael's total compensation ($USD1.33M) is about average for companies of similar size in the Canadian market ($USD1.29M).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Guerriere (58 yo)

5.5yrs

Tenure

CA$1,814,755

Compensation

Dr. Michael R. Guerriere, MD, MBA, has been the Chief Executive Officer and President at Extendicare Inc. since joined in October 22, 2018. Dr. Guerriere serves as Chairman and Chief Executive Officer of E...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Michael Guerriere	CEO, President & Director	5.5yrs	CA$1.81m	0.31% CA$ 1.9m
David Bacon	Senior VP & CFO	5yrs	CA$1.12m	0.15% CA$ 936.0k
Steve Paraskevopoulos	Senior Vice President of ParaMed & CTO	1.6yrs	CA$738.35k	0.036% CA$ 219.0k
John Toffoletto	Senior VP	4.4yrs	CA$966.91k	0.069% CA$ 417.8k
Matthew Morgan	Chief Medical Officer	3.5yrs	CA$655.99k	no data
Joe Belinsky	VP of Information Technology & Chief Information Officer	less than a year	no data	no data
Jillian Fountain	Vice President of Investor Relations	5.9yrs	CA$364.43k	0.054% CA$ 329.2k
Kathryn Bradley	Vice President of Corporate Development	1.3yrs	no data	0.014% CA$ 88.1k
Katie LeMoyne	Senior VP & Chief Human Resources Officer	1.3yrs	no data	0.027% CA$ 164.3k
Wendy Gilmour	Senior Vice President of Long-term Care Operations	1.3yrs	no data	no data
Amie Vahrmeyer	Vice President of Long-Term Care Operations for ON	no data	no data	no data

2.5yrs

Average Tenure

Experienced Management: EXE's management team is considered experienced (2.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Michael Guerriere	CEO, President & Director	6.1yrs	CA$1.81m	0.31% CA$ 1.9m
Alan Torrie	Independent Chairman of the Board	8.3yrs	CA$210.00k	0.042% CA$ 255.5k
Alvin Libin	Honorary Director	8.3yrs	CA$123.37k	no data
J. MacQuarrie	Honorary Director	8.3yrs	CA$180.37k	no data
Seth Goldsmith	Honorary Director	8.3yrs	CA$177.37k	no data
Alan Hibben	Independent Director	8.3yrs	CA$112.00k	0.086% CA$ 521.7k
Samir Manji	Independent Director	4.9yrs	CA$106.00k	0.012% CA$ 73.0k
Aladin Mawani	Independent Director	6.3yrs	CA$110.00k	0.030% CA$ 182.5k
Donna Kingelin	Independent Director	8.3yrs	CA$115.00k	0.0072% CA$ 43.8k
Sandra Hanington	Independent Director	9.7yrs	CA$110.00k	0.048% CA$ 290.5k
Brent M. Houlden	Independent Director	3.9yrs	CA$127.00k	0.026% CA$ 160.6k
Norma Beauchamp	Independent Director	4.9yrs	CA$100.00k	0.0048% CA$ 29.2k

8.3yrs

Average Tenure

69yo

Average Age

Experienced Board: EXE's board of directors are considered experienced (8.3 years average tenure).

Extendicare Management

Management criteria checks 4/4

Key information

Recent management updates

Extendicare Inc., Annual General Meeting, May 23, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Independent Director recently bought CA$99k worth of stock

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Recent updates

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023

Insufficient new directors

Independent Director recently bought CA$108k worth of stock

Upcoming dividend of CA$0.04 per share at 6.6% yield

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

Senior Vice President of ParaMed & CTO recently bought CA$206k worth of stock

Is Extendicare (TSE:EXE) Using Too Much Debt?

First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)

Upcoming dividend of CA$0.04 per share at 7.4% yield

CEO, President & Director recently bought CA$189k worth of stock

Upcoming dividend of CA$0.04 per share at 7.9% yield

CEO, President & Director exercised options to buy CA$258k worth of stock.

Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)

Upcoming dividend of CA$0.04 per share at 7.1% yield

Extendicare Inc. Declares Dividend for the Month of February 2023, Payable on March 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. to Report Q4, 2022 Results on Mar 02, 2023

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of January 2023, Payable on February 15, 2023

Upcoming dividend of CA$0.04 per share

Extendicare Inc. Declares Cash Dividend for the Month of December 2022, Payable on January 16, 2023

Independent Director recently bought CA$151k worth of stock

Upcoming dividend of CA$0.04 per share

Third quarter 2022 earnings released: CA$0.049 loss per share (vs CA$0.031 profit in 3Q 2021)

Third quarter 2022 earnings released: CA$0.041 loss per share (vs CA$0.027 profit in 3Q 2021)

Saskatchewan Health Authority acquired Ownership and operations of five Saskatchewan LTC homes from Extendicare Inc. (TSX : EXE) for CAD 13.1 million.

Extendicare Inc. Declares Dividend for the Month of November 2022, Payable on December 15, 2022

Upcoming dividend of CA$0.04 per share